Cargando…

Long-Term Effects of Fibrin Conduit with Human Mesenchymal Stem Cells and Immunosuppression after Peripheral Nerve Repair in a Xenogenic Model

INTRODUCTION: Previously we showed that a fibrin glue conduit with human mesenchymal stem cells (hMSCs) and cyclosporine A (CsA) enhanced early nerve regeneration. In this study long term effects of this conduit are investigated. METHODS: In a rat model, the sciatic nerve was repaired with fibrin co...

Descripción completa

Detalles Bibliográficos
Autores principales: McGrath, Aleksandra M., Brohlin, Maria, Wiberg, Rebecca, Kingham, Paul J., Novikov, Lev N., Wiberg, Mikael, Novikova, Liudmila N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172997/
https://www.ncbi.nlm.nih.gov/pubmed/32634185
http://dx.doi.org/10.1177/2155179018760327
_version_ 1783361051807449088
author McGrath, Aleksandra M.
Brohlin, Maria
Wiberg, Rebecca
Kingham, Paul J.
Novikov, Lev N.
Wiberg, Mikael
Novikova, Liudmila N.
author_facet McGrath, Aleksandra M.
Brohlin, Maria
Wiberg, Rebecca
Kingham, Paul J.
Novikov, Lev N.
Wiberg, Mikael
Novikova, Liudmila N.
author_sort McGrath, Aleksandra M.
collection PubMed
description INTRODUCTION: Previously we showed that a fibrin glue conduit with human mesenchymal stem cells (hMSCs) and cyclosporine A (CsA) enhanced early nerve regeneration. In this study long term effects of this conduit are investigated. METHODS: In a rat model, the sciatic nerve was repaired with fibrin conduit containing fibrin matrix, fibrin conduit containing fibrin matrix with CsA treatment and fibrin conduit containing fibrin matrix with hMSCs and CsA treatment, and also with nerve graft as control. RESULTS: At 12 weeks 34% of motoneurons of the control group regenerated axons through the fibrin conduit. CsA treatment alone or with hMSCs resulted in axon regeneration of 67% and 64% motoneurons respectively. The gastrocnemius muscle weight was reduced in the conduit with fibrin matrix. The treatment with CsA or CsA with hMSCs induced recovery of the muscle weight and size of fast type fibers towards the levels of the nerve graft group. DISCUSSION: The transplantation of hMSCs for peripheral nerve injury should be optimized to demonstrate their beneficial effects. The CsA may have its own effect on nerve regeneration.
format Online
Article
Text
id pubmed-6172997
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-61729972018-10-09 Long-Term Effects of Fibrin Conduit with Human Mesenchymal Stem Cells and Immunosuppression after Peripheral Nerve Repair in a Xenogenic Model McGrath, Aleksandra M. Brohlin, Maria Wiberg, Rebecca Kingham, Paul J. Novikov, Lev N. Wiberg, Mikael Novikova, Liudmila N. Cell Med Original Article INTRODUCTION: Previously we showed that a fibrin glue conduit with human mesenchymal stem cells (hMSCs) and cyclosporine A (CsA) enhanced early nerve regeneration. In this study long term effects of this conduit are investigated. METHODS: In a rat model, the sciatic nerve was repaired with fibrin conduit containing fibrin matrix, fibrin conduit containing fibrin matrix with CsA treatment and fibrin conduit containing fibrin matrix with hMSCs and CsA treatment, and also with nerve graft as control. RESULTS: At 12 weeks 34% of motoneurons of the control group regenerated axons through the fibrin conduit. CsA treatment alone or with hMSCs resulted in axon regeneration of 67% and 64% motoneurons respectively. The gastrocnemius muscle weight was reduced in the conduit with fibrin matrix. The treatment with CsA or CsA with hMSCs induced recovery of the muscle weight and size of fast type fibers towards the levels of the nerve graft group. DISCUSSION: The transplantation of hMSCs for peripheral nerve injury should be optimized to demonstrate their beneficial effects. The CsA may have its own effect on nerve regeneration. SAGE Publications 2018-05-31 /pmc/articles/PMC6172997/ /pubmed/32634185 http://dx.doi.org/10.1177/2155179018760327 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
McGrath, Aleksandra M.
Brohlin, Maria
Wiberg, Rebecca
Kingham, Paul J.
Novikov, Lev N.
Wiberg, Mikael
Novikova, Liudmila N.
Long-Term Effects of Fibrin Conduit with Human Mesenchymal Stem Cells and Immunosuppression after Peripheral Nerve Repair in a Xenogenic Model
title Long-Term Effects of Fibrin Conduit with Human Mesenchymal Stem Cells and Immunosuppression after Peripheral Nerve Repair in a Xenogenic Model
title_full Long-Term Effects of Fibrin Conduit with Human Mesenchymal Stem Cells and Immunosuppression after Peripheral Nerve Repair in a Xenogenic Model
title_fullStr Long-Term Effects of Fibrin Conduit with Human Mesenchymal Stem Cells and Immunosuppression after Peripheral Nerve Repair in a Xenogenic Model
title_full_unstemmed Long-Term Effects of Fibrin Conduit with Human Mesenchymal Stem Cells and Immunosuppression after Peripheral Nerve Repair in a Xenogenic Model
title_short Long-Term Effects of Fibrin Conduit with Human Mesenchymal Stem Cells and Immunosuppression after Peripheral Nerve Repair in a Xenogenic Model
title_sort long-term effects of fibrin conduit with human mesenchymal stem cells and immunosuppression after peripheral nerve repair in a xenogenic model
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172997/
https://www.ncbi.nlm.nih.gov/pubmed/32634185
http://dx.doi.org/10.1177/2155179018760327
work_keys_str_mv AT mcgrathaleksandram longtermeffectsoffibrinconduitwithhumanmesenchymalstemcellsandimmunosuppressionafterperipheralnerverepairinaxenogenicmodel
AT brohlinmaria longtermeffectsoffibrinconduitwithhumanmesenchymalstemcellsandimmunosuppressionafterperipheralnerverepairinaxenogenicmodel
AT wibergrebecca longtermeffectsoffibrinconduitwithhumanmesenchymalstemcellsandimmunosuppressionafterperipheralnerverepairinaxenogenicmodel
AT kinghampaulj longtermeffectsoffibrinconduitwithhumanmesenchymalstemcellsandimmunosuppressionafterperipheralnerverepairinaxenogenicmodel
AT novikovlevn longtermeffectsoffibrinconduitwithhumanmesenchymalstemcellsandimmunosuppressionafterperipheralnerverepairinaxenogenicmodel
AT wibergmikael longtermeffectsoffibrinconduitwithhumanmesenchymalstemcellsandimmunosuppressionafterperipheralnerverepairinaxenogenicmodel
AT novikovaliudmilan longtermeffectsoffibrinconduitwithhumanmesenchymalstemcellsandimmunosuppressionafterperipheralnerverepairinaxenogenicmodel